Veradermics, Incorporated IPO: offering terms from its S-1
Veradermics, Incorporated priced its IPO at $17 a share on 4 Feb 2026 and raised $256 million. Its shares trade on NYSE as MANE.
Headlines
- Net loss, 2024
- $26M
- IPO price
- $17
- $256M raised
Veradermics, Incorporated IPO terms
From the final prospectus (424B4).
- Exchange
- New York Stock Exchange
- Ticker
- MANE
- IPO price
- $17
- Shares offered
- 15,077,647
- Raised
- $256M
- Registered
- $1.7B, the amount the filing fee is paid on
- Underwriters
- Jefferies, Leerink Partners, Citigroup and Cantor
- First filed
- 9 Jan 2026
Veradermics, Incorporated revenue and profit
| Period | Revenue | Operating income | Net income |
|---|---|---|---|
| 2024 | - | -$27M | -$26M |
| First nine months of 2025 | - | -$49M | -$48M |
Veradermics, Incorporated share structure and company facts
- Employees
- 19
- Headquarters
- New Haven, Connecticut
Veradermics, Incorporated shares since the IPO
Latest close 26 Oct 2026
- IPO price
- $17
- Priced 4 Feb 2026
- First close
- $37.75
- +122% on the IPO price
- Latest close
- $137.39
- +708% on the IPO price
Veradermics, Incorporated's IPO filings
The registration statement, each amendment and the final prospectus, oldest first.
About the data
- Terms and financials are read from Veradermics, Incorporated's newest prospectus (424B4 filed 4 Feb 2026) by a Kadoa workflow. Check figures that matter against the filing.
- Registered is the amount the filing fee is paid on, often a placeholder before the price range is set.
- Raised is the IPO price times the shares sold, without the underwriters' option. Trading compares the first and latest close with the IPO price.